Skip to main content
Erschienen in: International Journal of Legal Medicine 1/2021

Open Access 07.07.2020 | Method Paper

Postmortem age estimation via DNA methylation analysis in buccal swabs from corpses in different stages of decomposition—a “proof of principle” study

verfasst von: Barbara Elisabeth Koop, Felix Mayer, Tanju Gündüz, Jacqueline Blum, Julia Becker, Judith Schaffrath, Wolfgang Wagner, Yang Han, Petra Boehme, Stefanie Ritz-Timme

Erschienen in: International Journal of Legal Medicine | Ausgabe 1/2021

Abstract

Age estimation based on the analysis of DNA methylation patterns has become a focus of forensic research within the past few years. However, there is little data available regarding postmortem DNA methylation analysis yet, and literature mainly encompasses analysis of blood from corpses without any signs of decomposition. It is not entirely clear yet which other types of specimen are suitable for postmortem epigenetic age estimation, and if advanced decomposition may affect methylation patterns of CpG sites. In living persons, buccal swabs are an easily accessible source of DNA for epigenetic age estimation. In this work, the applicability of this approach (buccal swabs as source of DNA) under different postmortem conditions was tested. Methylation levels of PDE4C were investigated in buccal swab samples collected from 73 corpses (0–90 years old; mean: 51.2) in different stages of decomposition. Moreover, buccal swab samples from 142 living individuals (0–89 years old; mean 41.2) were analysed. As expected, methylation levels exhibited a high correlation with age in living individuals (training set: r2 = 0.87, validation set: r2 = 0.85). This was also the case in postmortem samples (r2 = 0.90), independent of the state of decomposition. Only in advanced putrified cases with extremely low DNA amounts, epigenetic age estimation was not possible. In conclusion, buccal swabs are a suitable and easy to collect source for DNA methylation analysis as long as sufficient amounts of DNA are present.
Hinweise
Petra Boehme and Stefanie Ritz-Timme shared senior authorship

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

Epigenetic age estimation using “molecular clocks” [14] opens up new opportunities in forensic case work. The basis of such an epigenetic clock is an age-dependent methylation pattern at specific CpG sites. Several models for epigenetic age estimation have been described, which differ regarding number and combination of CpG sites (for review, see [5]). This new approach for age estimation can be used especially in the context of the analysis of crime scene samples [6] as well as for low- or non-invasive age estimation of living individuals based on easily accessible test material such as blood, saliva, or buccal swab samples (e.g., [711]).
Another forensic application for epigenetic age estimation may be age at death estimation of unknown deceased. Bekaert and colleagues [12] developed a 4-CpG-model (ASPA, PDE4C, ELOVL2 and EDARADD) using blood samples from 37 living and 169 deceased individuals. Estimated ages of the deceased were in accordance with those from living individuals. Similar results were reported by Hamano et al. [13] and Naue et al. [14] using two (ELOVL2 and FHL2) [13] and 13 CpG sites (RPA2, F5, TRIM59, KLF14, HOXC4, NKIRAS2, ZYG11 A, MEIS1, ELOVL2, GRM2, LDB2, SAMD2, DDO) [14], respectively. Additionally, the work of Naue et al. [14] revealed that methylation levels of several CpG sites were also associated with chronological age in several tissues collected postmortem including muscle, brain, bone and buccal swabs. The applicability of age estimation based on DNA methylation to postmortem tissues was also confirmed by further groups like Dias and colleagues for blood [15], Lee et al. for bone samples [16], Pfeifer et al. for blood [17] and Marquez-Ruiz et al. for teeth [18]. However, most authors either analysed only corpses in early stages of decomposition or did not describe the degree of decomposition in their cases.
Dias et al. [19] just recently pointed to possible postmortem changes of DNA methylation patterns. They investigated 62 blood samples, which were collected within 5 days after death and compared the results to those of samples from 59 living individuals. The authors concluded “that postmortem changes can occur in the methylation levels” and “postmortem changes can alter the methylation status among specific loci”.
Clarifying the raised question of postmortem changes in the DNA methylation pattern is a prerequisite for the application of age estimation based on DNA methylation to postmortem samples. To date, there are no systematic analyses regarding the effects of decomposition on epigenetic age estimation.
This study is intended to contribute to a better understanding of postmortem effects on DNA methylation. It focuses on whether epigenetic age estimation based on the analysis of buccal swabs is possible in cases with advanced postmortem decomposition. Buccal swabs from decedents were taken postmortem during different stages of decomposition. The degree of DNA methylation was assessed from 73 corpses and 142 living individuals for the highly age-associated CpG-1 site (upstream of cg17861230) of PDE4C in buccal swab samples.

Material and methods

Sample collection and assessment of decomposition

Buccal swabs were collected from 73 deceased individuals (age 0–90, mean: 51.2 years; 68.5% male) in different stages of decomposition and a postmortem interval (precisely known in 42 of the 73 cases) of 1–42 days. An additional 142 samples were taken from healthy living individuals (age 0–89 years, mean: 41.6 years; 41.5% male).
In cases of deceased individuals, macroscopically visible external changes of decomposition were described and the cases subsequently classified based on the proposed scorings by Megyesi et al. [20] (Table 1). Decomposition scores of the heads were used to group samples into the following categories with respect to their degree of decomposition: score 1 for no signs of decomposition (n = 21), score 2–3 for early signs of decomposition (n = 18), score 4–5 for signs of advanced decomposition (n = 22) and a score > 6 for severe signs of decomposition (n = 12).
Table 1
Scoring sheet for assessment of decomposition (Megyesi et al. [20])
Score
Signs of decomposition
1
Fresh, no discoloration
2
Pink-white appearance with skin slippage, some hair loss
3
Gray to green discoloration of skin
4
Drying of nose, ears and lips
5
Purging of decompositional fluids out of eyes, ears, nose, mouth
6
Muscle tissue brown-black
7
Caving in of facial tissue
8
Bones visible (< 50% of scoring area)
9
Mummification, bones visible > 50% of scoring area

DNA isolation and pyrosequencing

For genomic DNA isolation, NuceloSpin® Tissue Kit by Macherey-Nagel was used according to the manufacturer’s standard protocol for human tissue with overnight lysis. Extracted genomic DNA was stored at − 20 °C until further analysis. DNA quantity and quality were measured using the Investigator Quantiplex Pro Kit (Qiagen) via real-time PCR (Applied Biosystems™ 7500 Real-Time PCR Systems) following manufacturer’s instructions with default settings. For bisulfite conversion, the EZ DNA Methylation-Gold™ Kit (Zymo Research) was used following manufacturer’s instructions. When possible, the recommended amount of 200–500 ng of input DNA was applied. In some samples, the input was lower due to low original DNA amounts (Table 2). Bisulfite-converted DNA was amplified using the primers described by Weidner et al. [4] using the following thermal cycler conditions: 95 °C, 15 min; 45× cycles (95 °C, 30 s; 52 °C, 30 s; 72 °C, 30 s); 72 °C, 5 min; 4 °C, hold. The length of the subsequent product was 155 bp.
Table 2
Postmortem samples: DNA concentrations (ng/μl) and degradation indices (*: samples with DNA quantities too low for further application (≤ 3 ng/μl); score 1, no signs of decomposition, n = 21; score 2 + 3, early signs of decomposition, n = 18; scores 4 + 5, advanced decomposition, n = 22; score > 6, severe signs of decomposition, n = 12)
Score 1
ng/μl DNA
Degradation index
Score 2 + 3
ng/μl DNA
Degradation index
Score 4 + 5
ng/μl DNA
Degradation index
Score > 6
ng/μl DNA
Degradation index
L05
31.94
1.91
L03
84.62
1.48
L06
79.08
1.43
L01 *
0.00
Not applicable (degradation)
L08 *
0.03
42.57
L09
12.49
3.11
L15
38.53
6.18
L07 *
0.01
7.43
L12
14.59
1.43
L10
60.82
4.68
L16
60.94
2.31
L14 *
1.12
4.93
L21 *
0.01
6.01
L11
154.96
1.89
L19
102.89
1.22
L33 *
0.01
4.86
L22
27.92
5.32
L13
56.24
1.36
L28 *
0.00
4.34
L64 *
0.19
2.82
L23 *
0.02
12.69
L17
63.28
6.90
L30
70.12
2.13
L65 *
0.01
4.4
L25
12.58
1.32
L18
134.57
1.63
L34
72.12
15.34
L71 *
0.00
4.75
L26
110.62
1.82
L24
12.97
8.14
L36
66.14
8.79
L74 *
0.00
13.02
L27
33.44
1.28
L32
233.64
1.77
L39
45.85
6.64
L76 *
0.00
2.7
L29
66.13
1.63
L35 *
2.00
2.30
L42
3.55
4.28
L79 *
0.01
27.28
L31
16.69
2.30
L40
73.56
1.51
L44 *
1.04
10.54
L80
100.76
3.38
L37
9.65
1.86
L57
303.26
1.59
L45
97.53
1.82
L81 *
0.01
2.56
L43
56.78
1.62
L63
144.22
1.94
L46
33.03
3.58
   
L47
16.73
4.42
L69 *
0.00
23.26
L49
59.44
1.41
   
L50
74.78
2.07
L75
10.22
2.06
L51
80.71
5.24
   
L53
33.71
2.88
L77
93.60
3.62
L56
62.74
3.74
   
L54
36.53
1.74
L82
20.51
5.04
L58
122.19
2.75
   
L60 *
0.47
1.52
L83 *
0.00
5.00
L61
70.72
3.37
   
L70
63.45
2.63
   
L62
51.11
12.14
   
L73
90.10
1.65
   
L67 *
0.17
6.44
   
L78
134.01
2.67
   
L68
41.27
2.16
   
      
L72
49.28
2.59
   
Mean
39.53
4.83
 
81.16
4.29
 
54.93
4.93
 
8.51
7.10
Subsequently, the converted and amplified DNA was immobilized to 1 μl Streptavidin Sepharose™ HP beads (GE Healthcare). For pyrosequencing, the Pyromark Q24 and Pyromark Q24 Advanced Systems (Qiagen) were used. Sequencing primers were described in Weidner et al. [4]. All samples were measured at least in duplicate. Single values did not differ by more than 3% within one sample; this was also true for comparative measurements using both pyrosequencing systems (Q24, Q24 Advanced).

Data analysis

The relationship between chronological age and the methylation status of the highly age-associated CpG-1 site of PDE4C (upstream of cg17861230; see Weidner et al. [4]) was tested by linear regression and the corresponding correlation coefficients were determined. The samples of living individuals were split into two groups. One group was used as training set (n = 71, ages 0–89, mean age: 42 years), the other as validation set n = 71, ages 0–85, mean age: 42 years). Corpses with sufficient DNA yields (see Table 2) were treated as a second (postmortem) validation set (n = 52, ages 0–88, mean age: 49.5 years). The MADs (mean absolute deviations) of age estimates were calculated as mean of deviations of estimated from chronological ages.

Cytology of buccal swabs

Buccal swabs were taken from corpses in different stages of decomposition (scores 1, 5, and 7) and smears were prepared on specimen slides. The smears were stained with the Pappenheim method: after drying, the slides were immersed in undiluted May-Grünwald stain for 5 min, rinsed with distilled water, immersed in Giemsa stain diluted with distilled water in a ratio of 1:9 for 15 min before being rinsed again with distilled water. After staining, images of the smears were taken with the Nikon C-TEP3 system with a 100-fold magnification.

Results

DNA yields were unexpectedly high in postmortem samples—apart from cases with severe decomposition (score > 6)

DNA quantities varied considerably within both groups (living and deceased) and ranged between < 1.0 and 303.3 ng/μl (Table 2). In several postmortem samples, DNA yields were unexpectedly high, albeit, in the group with severe signs of decomposition (score > 6), only one sample (L80) contained sufficient amounts of DNA for further analysis. The number of samples with low DNA amounts increased with increasing decomposition. Thus, the manufacturer’s recommended input of 200–500 ng of template DNA for bisulfite conversion was only possible for 52 of 73 samples of deceased (Table 2). There was no relationship between degradation indices and DNA yields or macroscopically assessed scores of decomposition for samples of scores below 6 (Table 2). Degradation indices over 10 (indicating a possible degradation) were seen in only few cases in all score groups (2 of 21 cases of score 1, 1 of 18 cases of score 2 + 3, 3 of 22 cases of score 4 + 5, and 2 of 11 cases of score > 6). Samples with high degradation indices neither showed pyrograms of low quality nor values that do not correspond to the age of the individuals.
Smear cell preparations from buccal swabs showed a significant increase of buccal cells in preparations from corpses with signs of decomposition up to score 5, as compared to corpses without signs of decomposition (score 1) (Fig. 1). However, in corpses with advanced decomposition, nearly no intact buccal cells could be found (example in Fig. 1: score 7).

Ante- and postmortem samples exhibit a similar and close correlation between DNA methylation and chronological age

Statistical analyses of the training set (71 living individuals) showed a close relationship between age and DNA methylation (r2 = 0.87), which can be described by the following equation:
estimated age = (methylation of CpG-1 in PDE4C − 9.5485) / 0.4797
Application of this formula to both validation groups (71 living individuals, 52 corpses) revealed a similar and close relationship between chronological and estimated age for all groups (Fig. 2, validation set living: r2 = 0.85, validation set corpses: r2 = 0.90), the MADs were 7.8 years for the validation set of living individuals, and 9.1 years for the postmortem samples.

The state of decomposition does not affect the scattering of methylation levels in the postmortem samples

To assess the impact of decomposition on methylation-dependent age estimation, the regression of samples within each decomposition state was plotted for the chronological age vs. the degree of PDE4C CpG-1 methylation (Fig. 3). There is no indication for a relevant influence of the state of decomposition on the scattering of data. Due to the low number of cases and differences in distribution of chronological ages in each group of decomposition state, further statistical processing was not carried out.

Discussion

The application of epigenetic age estimation to postmortem cases requires systematic analyses regarding the effects of decomposition. This study focused on the applicability of epigenetic age estimation under different postmortem conditions, including stages of advanced decomposition using buccal swabs as the source of DNA [21].

DNA yields of swabs were unexpectedly high in the postmortem cases with signs of decomposition (below a score of 6)

In many cases with moderate signs of decomposition, the amount of DNA isolated from corpses was unexpectedly high. This may be because the decomposition processes affect the stability of buccal mucosa. More cells may be available on the swab in deceased individuals with signs of decomposition compared to swabs taken from intact buccal mucosa of living individuals. This hypothesis is supported by the analysis of smear preparations of buccal swabs from corpses in different stages of decomposition (Fig. 1).
Degradation indices over 10 (indicating a possible degradation) were seen in only few cases, surprisingly even in the score groups of advanced decomposition of the bodies. These findings obviously reflect that putrefaction processes differ greatly from one individual to another, depending on many ante- and postmortem factors as bacterial colonization, temperature, and blood congestion or hypostasis.
However, DNA yields of swabs from corpses in very severe stages of decomposition (with scores > 6, see Table 1) were minute in all but one individual. This might not be surprising, as in those stages of decomposition tissues start to dry out. Later on, buccal mucosa is dried out or even nearly totally dissolved.

Ante- and postmortem samples exhibit a very similar and close correlation between DNA methylation and chronological age and the state of decomposition does not affect the scattering of methylation levels

Eipel et al. [21] addressed the importance of buccal cell composition for the precision of epigenetic age estimation, as it is already known that DNA methylation is tissue- and cell-type dependent. However, their work described that the PDE4C marker seems to be rather robust to changes in cell composition (buccal epithelial cells vs. leukocytes). On the other hand, one might have assumed that postmortem PDE4C methylation levels may be influenced, changed, or even be unmeasurable due to post- or perimortem cellular processes or bacterial activity. Although only a small number of samples and only one DNA methylation marker was analysed in the present study, the collected data do not give any indication of such influences. Therefore, our data for buccal swabs are in line with results from blood samples of corpses presented in other studies, which also did not find differences in epigenetic age estimations of living vs. deceased [1215]. By this, we also proved the robustness of the PDE4C marker towards changes in cellular composition described by Eipel et al. [21].

Conclusion

Our data suggest that epigenetic age estimation based on the analysis of buccal swabs is applicable even in cases with advanced decomposition, as long as enough intact DNA can be extracted.
In this “proof of principle” study, we analysed only one type of specimen (buccal swabs), a limited number of samples and only one DNA methylation marker. Hence, systematic postmortem studies including diverse tissues and diverse marker combinations as well as cases with different stages of decomposition are required to exploit the full potential of epigenetic age estimation for postmortem application. Based on the results of such studies, epigenetic age estimation will doubtlessly expand the methodological repertoire for postmortem age estimation. It will be especially valuable in combination with other methods, as such combinations are proven to reduce errors [22].

Acknowledgements

Open Access funding provided by Projekt DEAL. Special thanks to Associate Prof. Dr. Christine J. Picard and Dr. Marietta Wolter for helpful suggestions.

Compliance with ethical standards

Conflict of interest

W.W. is cofounder of Cygenia GmbH (www.​cygenia.​com), which can provide service for other scientists for epigenetic age predictions. Y.H. contributes to this company, too.

Ethics approval

All procedures performed in studies involving human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (approved by Ethics Committees at the Medical Faculty of Heinrich-Heine University (4939) and of RWTH/University Clinic Aachen (EK 041/15)). This article does not contain any studies with animals performed by any of the authors.

Code availability (software application or custom code)

Not applicable.
Not applicable.
Not applicable.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
3.
Zurück zum Zitat Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y, Whitsel EA, Wilson JG, Reiner AP, Aviv A, Lohman K, Liu Y, Ferrucci L, Horvath S (2018) An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY) 10(4):573–591. https://doi.org/10.18632/aging.101414CrossRef Levine ME, Lu AT, Quach A, Chen BH, Assimes TL, Bandinelli S, Hou L, Baccarelli AA, Stewart JD, Li Y, Whitsel EA, Wilson JG, Reiner AP, Aviv A, Lohman K, Liu Y, Ferrucci L, Horvath S (2018) An epigenetic biomarker of aging for lifespan and healthspan. Aging (Albany NY) 10(4):573–591. https://​doi.​org/​10.​18632/​aging.​101414CrossRef
20.
Zurück zum Zitat Megyesi MS, Nawrocki SP, Haskell NH (2005) Using accumulated degree-days to estimate the postmortem interval from decomposed human remains. J Forensic Sci 50(3):618–626CrossRef Megyesi MS, Nawrocki SP, Haskell NH (2005) Using accumulated degree-days to estimate the postmortem interval from decomposed human remains. J Forensic Sci 50(3):618–626CrossRef
21.
Zurück zum Zitat Eipel M, Mayer F, Arent T, Ferreira MR, Birkhofer C, Gerstenmaier U, Costa IG, Ritz-Timme S, Wagner W (2016) Epigenetic age predictions based on buccal swabs are more precise in combination with cell type-specific DNA methylation signatures. Aging (Albany NY) 8(5):1034–1048. https://doi.org/10.18632/aging.100972CrossRef Eipel M, Mayer F, Arent T, Ferreira MR, Birkhofer C, Gerstenmaier U, Costa IG, Ritz-Timme S, Wagner W (2016) Epigenetic age predictions based on buccal swabs are more precise in combination with cell type-specific DNA methylation signatures. Aging (Albany NY) 8(5):1034–1048. https://​doi.​org/​10.​18632/​aging.​100972CrossRef
Metadaten
Titel
Postmortem age estimation via DNA methylation analysis in buccal swabs from corpses in different stages of decomposition—a “proof of principle” study
verfasst von
Barbara Elisabeth Koop
Felix Mayer
Tanju Gündüz
Jacqueline Blum
Julia Becker
Judith Schaffrath
Wolfgang Wagner
Yang Han
Petra Boehme
Stefanie Ritz-Timme
Publikationsdatum
07.07.2020
Verlag
Springer Berlin Heidelberg
Erschienen in
International Journal of Legal Medicine / Ausgabe 1/2021
Print ISSN: 0937-9827
Elektronische ISSN: 1437-1596
DOI
https://doi.org/10.1007/s00414-020-02360-7

Weitere Artikel der Ausgabe 1/2021

International Journal of Legal Medicine 1/2021 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin